Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma
RIS ID
74493
Abstract
Background: Interleukin-17 (IL-17) is a CD4 T-cell-derived mediator of angiogenesis that stimulates vascular endothelial cell migration and regulates the production of a variety of proangiogenic factors, such as tumor necrosis factor-α (TNF-α) and vascular endothelial cell growth factor (VEGF). Angiogenesis is implicated in the progression of multiple myeloma (MM). Methods: We measured serum levels of IL-17, TNF-α, and VEGF, as well as microvessel density (MVD) in 40 untreated MM patients. Results: Levels of IL-17 in the sera of patients with MM were higher than those in matched controls; however, the difference did not reach statistical significance. Serum levels of both TNF-α and VEGF in MM patients were significantly higher than those in controls (p
Publication Details
Alexandrakis, M., Pappa, C., Miyakis, S., Sfiridaki, A., Kafousi, M., Alegakis, A. & Stathopoulos, E. (2006). Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma. European Journal of Internal Medicine, 17(6) 412-416.